Hengst J C, Kan-Mitchell J, Kempf R A, Strumpf I J, Sharma O P, Kortes V L, Mitchell M S
Cancer Res. 1985 Jan;45(1):459-63.
We have reported previously that pulmonary alveolar macrophages (PAMs) from individuals with lung cancer and active chronic pulmonary diseases were cytotoxic to tumor cells in vitro, whereas PAMs from normal individuals or patients with acute pulmonary disorders were noncytotoxic. In the present study, we evaluated 20 PAM preparations for both suppressor and cytotoxic functions to determine if PAMs could function as suppressor cells and, if so, whether a correlation between the two functions exists. Cytotoxicity was assessed in a 60-hr cytotoxicity assay against [3H]proline-prelabeled human melanoma target cells. More than 20% cytotoxicity was considered to be significant. Suppressor activity was measured by determining whether admixing PAMs at various ratios with autologous or allogeneic mononuclear cells could suppress concanavalin A-induced blastogenesis by T-lymphocytes. At least 50% suppression was considered to be significant. Of the 20 specimens evaluated, 13 were cytotoxic and 5 of these exhibited suppressor activity. None of the 7 noncytotoxic PAM preparations had suppressor activity. Suppression was nonspecific and not HLA restricted, since autologous and allogeneic mononuclear cells were inhibited to a similar extent. Suppression was probably not due to prostaglandin production by the PAMs since assays were performed under optimal conditions and required extremely high concentrations of prostaglandins. A significant correlation between suppressor and cytotoxic activity was found. Suppression was observed only with PAM specimens that were also highly cytotoxic to tumors, but not all cytotoxic PAM specimens were suppressive. Whether these actions reflect different levels of activation of PAMs or are the properties of different macrophage subsets remains to be clarified.
我们之前报道过,肺癌患者和活动性慢性肺部疾病患者的肺泡巨噬细胞(PAM)在体外对肿瘤细胞具有细胞毒性,而正常个体或急性肺部疾病患者的PAM则无细胞毒性。在本研究中,我们评估了20份PAM制剂的抑制和细胞毒性功能,以确定PAM是否可作为抑制细胞发挥作用,如果是,这两种功能之间是否存在相关性。细胞毒性通过针对[3H]脯氨酸预标记的人黑色素瘤靶细胞的60小时细胞毒性试验进行评估。超过20%的细胞毒性被认为具有显著性。通过确定以不同比例将PAM与自体或异体单核细胞混合是否能抑制T淋巴细胞的伴刀豆球蛋白A诱导的增殖来测量抑制活性。至少50%的抑制被认为具有显著性。在评估的20个样本中,13个具有细胞毒性,其中5个表现出抑制活性。7个无细胞毒性的PAM制剂均无抑制活性。抑制是非特异性的且不受HLA限制,因为自体和异体单核细胞受到的抑制程度相似。抑制可能不是由于PAM产生前列腺素,因为试验是在最佳条件下进行的,且需要极高浓度的前列腺素。发现抑制和细胞毒性活性之间存在显著相关性。仅在对肿瘤也具有高细胞毒性的PAM样本中观察到抑制作用,但并非所有具有细胞毒性的PAM样本都具有抑制作用。这些作用是反映了PAM不同水平的激活还是不同巨噬细胞亚群的特性,仍有待阐明。